{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["da708c83-e61e-43d9-b2de-ccb53eee25d4", "Q3", 24338, "MCDERMOTT WILL & SCHULTE LLP", 131899, "ISIS PHARMACEUTICALS", 2010, "third_quarter", "2010-10-19T17:23:25.097000-04:00", 75000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/da708c83-e61e-43d9-b2de-ccb53eee25d4/\", \"filing_uuid\": \"da708c83-e61e-43d9-b2de-ccb53eee25d4\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2010, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/da708c83-e61e-43d9-b2de-ccb53eee25d4/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"75000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Stephen M. Ryan, Partner\", \"dt_posted\": \"2010-10-19T17:23:25.097000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"600 13th Street NW\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20005\", \"registrant\": {\"id\": 24338, \"url\": \"https://lda.senate.gov/api/v1/registrants/24338/\", \"house_registrant_id\": 31445, \"name\": \"MCDERMOTT WILL & SCHULTE LLP\", \"description\": \"Law Firm\", \"address_1\": \"500 North Capitol Street, NW\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20001\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ERIC ZIMMERMAN\", \"contact_telephone\": \"+1 202-204-1457\", \"dt_updated\": \"2026-01-14T11:28:33.077433-05:00\"}, \"client\": {\"id\": 131899, \"url\": \"https://lda.senate.gov/api/v1/clients/131899/\", \"client_id\": 1005433, \"name\": \"ISIS PHARMACEUTICALS\", \"general_description\": \"pharmaceutical research company\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2013-03-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40292, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"STEPHEN\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"RYAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Deputy Counsel, President's Commission on\", \"new\": false}, {\"lobbyist\": {\"id\": 46579, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"DUANE\", \"last_name\": \"RANSOM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Member)\", \"new\": false}, {\"lobbyist\": {\"id\": 46474, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SHEILA\", \"nickname\": null, \"middle_name\": \"D\", \"last_name\": \"WALCOFF\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Representatives\", \"new\": false}, {\"lobbyist\": {\"id\": 41606, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KAREN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SEALANDER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40292, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"STEPHEN\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"RYAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Organized Crime.\", \"new\": false}, {\"lobbyist\": {\"id\": 46579, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"DUANE\", \"last_name\": \"RANSOM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Member).\", \"new\": false}, {\"lobbyist\": {\"id\": 46474, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SHEILA\", \"nickname\": null, \"middle_name\": \"D\", \"last_name\": \"WALCOFF\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Representatives.\", \"new\": false}, {\"lobbyist\": {\"id\": 41606, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KAREN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SEALANDER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40292, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"STEPHEN\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"RYAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Organized Crime.\", \"new\": false}, {\"lobbyist\": {\"id\": 46579, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"DUANE\", \"last_name\": \"RANSOM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Member).\", \"new\": false}, {\"lobbyist\": {\"id\": 46474, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SHEILA\", \"nickname\": null, \"middle_name\": \"D\", \"last_name\": \"WALCOFF\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Representatives.\", \"new\": false}, {\"lobbyist\": {\"id\": 41606, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KAREN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SEALANDER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["da708c83-e61e-43d9-b2de-ccb53eee25d4"], "units": {}, "query_ms": 37.722085136920214, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}